JP2008545700A5 - - Google Patents

Download PDF

Info

Publication number
JP2008545700A5
JP2008545700A5 JP2008513703A JP2008513703A JP2008545700A5 JP 2008545700 A5 JP2008545700 A5 JP 2008545700A5 JP 2008513703 A JP2008513703 A JP 2008513703A JP 2008513703 A JP2008513703 A JP 2008513703A JP 2008545700 A5 JP2008545700 A5 JP 2008545700A5
Authority
JP
Japan
Prior art keywords
group
ether
compound represented
atom
ether group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008513703A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008545700A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/020226 external-priority patent/WO2006127893A2/en
Publication of JP2008545700A publication Critical patent/JP2008545700A/ja
Publication of JP2008545700A5 publication Critical patent/JP2008545700A5/ja
Pending legal-status Critical Current

Links

JP2008513703A 2005-05-25 2006-05-25 4−(ビフェニリル)アゼチジン−2−オンホスホン酸類の製造方法 Pending JP2008545700A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68448105P 2005-05-25 2005-05-25
PCT/US2006/020226 WO2006127893A2 (en) 2005-05-25 2006-05-25 Processes for production of 4-(biphenylyl)azetidin-2-one phosphonic acids

Publications (2)

Publication Number Publication Date
JP2008545700A JP2008545700A (ja) 2008-12-18
JP2008545700A5 true JP2008545700A5 (enExample) 2009-07-30

Family

ID=37103301

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008513703A Pending JP2008545700A (ja) 2005-05-25 2006-05-25 4−(ビフェニリル)アゼチジン−2−オンホスホン酸類の製造方法

Country Status (15)

Country Link
US (1) US20090099355A1 (enExample)
EP (1) EP1896135A2 (enExample)
JP (1) JP2008545700A (enExample)
KR (1) KR20080025077A (enExample)
CN (1) CN101222950A (enExample)
AU (1) AU2006249905A1 (enExample)
BR (1) BRPI0611415A2 (enExample)
CA (1) CA2609506A1 (enExample)
EA (1) EA200702614A1 (enExample)
IL (1) IL187626A0 (enExample)
MA (1) MA29553B1 (enExample)
NO (1) NO20076597L (enExample)
TW (1) TW200801027A (enExample)
WO (1) WO2006127893A2 (enExample)
ZA (1) ZA200710857B (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0215579D0 (en) 2002-07-05 2002-08-14 Astrazeneca Ab Chemical compounds
DE602004008100T2 (de) * 2003-11-10 2008-04-30 Microbia Inc., Cambridge 4-biarylyl-1-phenylazetidin-2-one
WO2005061452A1 (en) 2003-12-23 2005-07-07 Astrazeneca Ab Diphenylazetidinone derivates possessing cholesterol absorption inhibitory activity
US20060135755A1 (en) 2004-12-20 2006-06-22 Schering Corporation Process for the synthesis of azetidinones
UY29607A1 (es) 2005-06-20 2007-01-31 Astrazeneca Ab Compuestos quimicos
SA06270191B1 (ar) 2005-06-22 2010-03-29 استرازينيكا ايه بي مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم
MY148538A (en) 2005-06-22 2013-04-30 Astrazeneca Ab Novel 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions
DE102005055726A1 (de) * 2005-11-23 2007-08-30 Sanofi-Aventis Deutschland Gmbh Hydroxy-substituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
AR060623A1 (es) 2006-04-27 2008-07-02 Astrazeneca Ab Compuestos derivados de 2-azetidinona y un metodo de preparacion
JP2010500300A (ja) 2006-08-08 2010-01-07 サノフィ−アベンティス アリールアミノアリール−アルキル−置換イミダゾリジン−2,4−ジオン、それらの製造法、それらの化合物を含有する薬剤、およびそれらの使用
WO2008061238A2 (en) * 2006-11-16 2008-05-22 Ironwood Pharmaceuticals, Inc. Processes for production of 4-biphenylyazetidin-2-ones
EP2025674A1 (de) 2007-08-15 2009-02-18 sanofi-aventis Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE102007063671A1 (de) 2007-11-13 2009-06-25 Sanofi-Aventis Deutschland Gmbh Neue kristalline Diphenylazetidinonhydrate, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
WO2009157019A2 (en) * 2008-06-23 2009-12-30 Ind-Swift Laboratories Limited Process for preparing ezetimibe using novel allyl intermediates
UY31968A (es) 2008-07-09 2010-01-29 Sanofi Aventis Nuevos derivados heterocíclicos, sus procesos para su preparación, y sus usos terapéuticos
WO2010068601A1 (en) 2008-12-08 2010-06-17 Sanofi-Aventis A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
RU2012111354A (ru) 2009-08-26 2013-10-10 Санофи Новые кристаллические гидраты фторгликозидов, содержащие их фармацевтические препараты и их использование
WO2011157827A1 (de) 2010-06-18 2011-12-22 Sanofi Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen
WO2012120053A1 (de) 2011-03-08 2012-09-13 Sanofi Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2012120056A1 (de) 2011-03-08 2012-09-13 Sanofi Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2012120055A1 (de) 2011-03-08 2012-09-13 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2012120052A1 (de) 2011-03-08 2012-09-13 Sanofi Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
US8828994B2 (en) 2011-03-08 2014-09-09 Sanofi Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
CN102285932B (zh) * 2011-09-01 2013-06-12 浙江大学 一种依替米贝中间体的制备方法
KR102062343B1 (ko) * 2011-12-30 2020-01-02 다우 아그로사이언시즈 엘엘씨 4-클로로-2-플루오로-3-치환된-페닐보론산 피나콜 에스테르의 형성 방법 및 그의 사용 방법
CN103396429B (zh) * 2013-06-28 2016-05-25 杭州师范大学 一种硅手性中心的硅烷衍生物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT67341A (en) * 1991-07-23 1995-03-28 Schering Corp Substituted beta-lactam compounds useful as hypocholesterolemic agents, pharmaceutical compositions containing the same and process for the production thereof
US5631365A (en) * 1993-09-21 1997-05-20 Schering Corporation Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
CA2158191A1 (en) * 1994-09-16 1996-03-17 Junji Yokoi Method for preventing settlement of aquatic fouling organisms
ES2244238T3 (es) * 1998-12-07 2005-12-01 Schering Corporation Proceso para la sintesis de azetidinonas.
US6207822B1 (en) * 1998-12-07 2001-03-27 Schering Corporation Process for the synthesis of azetidinones
IL156552A0 (en) * 2000-12-21 2004-01-04 Aventis Pharma Gmbh Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
WO2002050027A1 (de) * 2000-12-21 2002-06-27 Aventis Pharma Deutschland Gmbh Neue diphenzylazetidinone, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung zur behandlung von lipidstoffwechselstörungen
TWI291957B (en) * 2001-02-23 2008-01-01 Kotobuki Pharmaceutical Co Ltd Beta-lactam compounds, process for repoducing the same and serum cholesterol-lowering agents containing the same
DE60206365T2 (de) * 2001-03-28 2006-07-06 Schering Corporation, Kenilworth Verfahren für die enantioselektive synthese von azetidinon-zwischenprodukten
CN1805926A (zh) * 2003-05-05 2006-07-19 兰贝克赛实验室有限公司 二苯基氮杂环丁酮衍生物的反式异构体的制备方法
DE602004008100T2 (de) * 2003-11-10 2008-04-30 Microbia Inc., Cambridge 4-biarylyl-1-phenylazetidin-2-one
US20090005321A1 (en) * 2005-02-09 2009-01-01 Microbia, Inc. Phenylazetidinone Derivatives
TW200726746A (en) * 2005-05-06 2007-07-16 Microbia Inc Processes for production of 4-biphenylylazetidin-2-ones
US20080200669A1 (en) * 2005-05-11 2008-08-21 Microbia, Inc. Processes For Production of Phenolic 4-Biphenylylazetidin-2-Ones

Similar Documents

Publication Publication Date Title
JP2008545700A5 (enExample)
JP2008540557A5 (enExample)
JP2004536811A5 (enExample)
JP2007524706A5 (enExample)
JP2013538849A5 (enExample)
JP2013520495A5 (enExample)
RU2013114370A (ru) Производные эфиров фосфоновых кислот и способы их синтеза
JP2017210484A5 (enExample)
JP2004528385A5 (enExample)
JP2004504323A5 (enExample)
JP5115477B2 (ja) 水酸基を有する3−エチルオキセタン化合物及びその製法
JP2011507941A5 (enExample)
JP2008526897A5 (enExample)
JP2008542205A5 (enExample)
JP2006514956A5 (enExample)
ES2235648B1 (es) Procedimiento para la obtencion de tolterodina.
JP5257353B2 (ja) 置換ヒドロキシメチルフェノールの新規な合成
JP2014520796A5 (enExample)
RU2007104036A (ru) Способ получения диизопропил (гидроксиметил)-циклопропил)окси) метилфосфоната
JP4018546B2 (ja) 3−(z)−プロペニルセフェム化合物の選択的な製造方法
JP2008231223A (ja) 新規なオキセタン化ノボラック樹脂及びその製法
JP2002516895A (ja) 保護ジヒドロキシプロピルトリアルキルアンモニウム塩およびそれらの誘導体の調製方法
ES2522549T3 (es) Procedimiento para la preparación de 2-hidroxi-4-fenil-3,4-dihidro-2H-cromen-6-il-metanol y (R)-feso-deacilo
JP4513535B2 (ja) トルテロジンの製造方法
JP2004505073A (ja) 鎮咳活性を有する1,3−ジオキソラン